Lean body mass as an independent determinant of dose‐limiting toxicity and neuropathy in patients with colon cancer treated with FOLFOX regimens-Reference-Cited by-同舟云学术

Lean body mass as an independent determinant of dose‐limiting toxicity and neuropathy in patients with colon cancer treated with FOLFOX regimens

Author:

Ali Raafi¹,Baracos Vickie E.¹,Sawyer Michael B.¹,Bianchi Laurent²,Roberts Sarah¹,Assenat Eric³,Mollevi Caroline⁴,Senesse Pierre²⁵

Affiliation:

1. Department of Oncology University of Alberta Edmonton Canada

2. Department of Clinical Nutrition and Gastroenterology Institute of Cancer Montpellier Montpellier France

3. Department of Gastroenterology University Hospital Montpellier France Montpellier France

4. Biometrics Unit – CTD INCa Institut régional du Cancer de Montpellier (ICM) Montpellier France

5. SIRIC Montpellier Cancer Institut régional du Cancer de Montpellier (ICM) Montpellier France

Funder

Alberta Cancer Foundation

Canadian Institutes of Health Research

Publisher

Wiley

Subject

Cancer Research,Radiology Nuclear Medicine and imaging,Oncology

Link

Reference37 articles.

Cited by 124 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献